메뉴 건너뛰기




Volumn 22, Issue 3, 2016, Pages 278-287

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

(30)  Noll, Elisa M a,b   Eisen, Christian a,b   Stenzinger, Albrecht b,c,h   Espinet, Elisa a,b   Muckenhuber, Alexander c,i   Klein, Corinna a   Vogel, Vanessa a   Klaus, Bernd d   Nadler, Wiebke a,b   Rösli, Christoph a,j   Lutz, Christian e   Kulke, Michael e   Engelhardt, Jan a,b   Zickgraf, Franziska M a,b   Espinosa, Octavio b   Schlesner, Matthias b   Jiang, Xiaoqi b   Kopp Schneider, Annette b   Neuhaus, Peter f   Bahra, Marcus f   more..


Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A5; DASATINIB; ERLOTINIB; HEPATOCYTE NUCLEAR FACTOR 4; PACLITAXEL; SHORT HAIRPIN RNA; CYP3A5 PROTEIN, HUMAN; CYTOCHROME P450 3A; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HNF1A PROTEIN, HUMAN; HNF4A PROTEIN, HUMAN; KERATIN; KERATIN TYPE II; KRT81 PROTEIN, HUMAN; PREGNANE X RECEPTOR; PROTEIN KINASE INHIBITOR; STEROID RECEPTOR; TUMOR MARKER;

EID: 84957640649     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4038     Document Type: Article
Times cited : (174)

References (67)
  • 1
    • 77951755278 scopus 로고    scopus 로고
    • Pancreatic cancer
    • Hidalgo, M. Pancreatic cancer. N. Engl. J. Med. 362, 1605-1617 (2010
    • (2010) N. Engl. J. Med , vol.362 , pp. 1605-1617
    • Hidalgo, M.1
  • 4
    • 8244254377 scopus 로고    scopus 로고
    • Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
    • Burris, H.A. III et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. 15, 2403-2413 (1997
    • (1997) J. Clin. Oncol , vol.15 , pp. 2403-2413
    • Burris, H.A.1
  • 5
    • 79955921754 scopus 로고    scopus 로고
    • FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
    • Conroy, T. et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N. Engl. J. Med. 364, 1817-1825 (2011
    • (2011) N. Engl. J. Med , vol.364 , pp. 1817-1825
    • Conroy, T.1
  • 6
    • 84886741654 scopus 로고    scopus 로고
    • Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
    • Von Hoff, D.D. et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N. Engl. J. Med. 369, 1691-1703 (2013
    • (2013) N. Engl. J. Med , vol.369 , pp. 1691-1703
    • Von Hoff, D.D.1
  • 8
    • 34249933404 scopus 로고    scopus 로고
    • Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase 3 trial of the National Cancer Institute of Canada clinical trials group
    • Moore, M.J. et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase 3 trial of the National Cancer Institute of Canada clinical trials group. J. Clin. Oncol. 25, 1960-1966 (2007
    • (2007) J. Clin. Oncol , vol.25 , pp. 1960-1966
    • Moore, M.J.1
  • 9
    • 84944073483 scopus 로고    scopus 로고
    • Subtyping pancreatic cancer
    • Biankin, A.V. & Maitra, A. Subtyping pancreatic cancer. Cancer Cell 28, 411-413 (2015
    • (2015) Cancer Cell , vol.28 , pp. 411-413
    • Biankin, A.V.1    Maitra, A.2
  • 10
    • 84965188725 scopus 로고    scopus 로고
    • Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer
    • Kim, S. et al. Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer. Biomed. Eng. Online 13, S5 (2014
    • (2014) Biomed. Eng. Online , vol.13 , pp. S5
    • Kim, S.1
  • 11
    • 79953756460 scopus 로고    scopus 로고
    • Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
    • Collisson, E.A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500-503 (2011
    • (2011) Nat. Med , vol.17 , pp. 500-503
    • Collisson, E.A.1
  • 12
    • 84855945142 scopus 로고    scopus 로고
    • 2nd edn. (ed. McQueen, C.A.) 9.43-9.76 Elsevier Ltd., Oxford
    • Guengrich, F.P. in Comprehensive Toxicology 2nd edn. (ed. McQueen, C.A.) 9.43-9.76 (Elsevier Ltd., Oxford, 2010
    • (2010) Comprehensive Toxicology
    • Guengrich, F.P.1
  • 13
    • 18644380835 scopus 로고    scopus 로고
    • Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: Focus on tamoxifen, paclitaxel and imatinib metabolism
    • Rochat, B. Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism. Clin. Pharmacokinet. 44, 349-366 (2005
    • (2005) Clin. Pharmacokinet , vol.44 , pp. 349-366
    • Rochat, B.1
  • 14
    • 34249930470 scopus 로고    scopus 로고
    • Targeting cytochrome P450 enzymes: A new approach in anticancer drug development
    • Bruno, R.D. & Njar, V.C.O. Targeting cytochrome P450 enzymes: a new approach in anticancer drug development. Bioorg. Med. Chem. 15, 5047-5060 (2007
    • (2007) Bioorg. Med. Chem , vol.15 , pp. 5047-5060
    • Bruno, R.D.1    Njar, V.C.O.2
  • 15
    • 37349067079 scopus 로고    scopus 로고
    • Drug metabolism by tumors: Its nature, relevance and therapeutic implications
    • Michael, M. & Doherty, M.M. Drug metabolism by tumors: its nature, relevance and therapeutic implications. Expert Opin. Drug Metab. Toxicol. 3, 783-803 (2007
    • (2007) Expert Opin. Drug Metab. Toxicol , vol.3 , pp. 783-803
    • Michael, M.1    Doherty, M.M.2
  • 16
    • 84887425166 scopus 로고    scopus 로고
    • Evolution and dynamics of pancreatic cancer progression
    • Yachida, S. & Iacobuzio-Donahue, C.A. Evolution and dynamics of pancreatic cancer progression. Oncogene 32, 5253-5260 (2013
    • (2013) Oncogene , vol.32 , pp. 5253-5260
    • Yachida, S.1    Iacobuzio-Donahue, C.A.2
  • 17
    • 84869091997 scopus 로고    scopus 로고
    • Pancreatic cancer genomes reveal aberrations in axon-guidance pathway genes
    • Biankin, A.V. et al. Pancreatic cancer genomes reveal aberrations in axon-guidance pathway genes. Nature 491, 399-405 (2012
    • (2012) Nature , vol.491 , pp. 399-405
    • Biankin, A.V.1
  • 18
    • 52149123619 scopus 로고    scopus 로고
    • Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
    • Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806 (2008
    • (2008) Science , vol.321 , pp. 1801-1806
    • Jones, S.1
  • 19
    • 78650034777 scopus 로고    scopus 로고
    • Toward a knowledge-based Human Protein Atlas
    • Uhlen, M. et al. Toward a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-1250 (2010
    • (2010) Nat. Biotechnol , vol.28 , pp. 1248-1250
    • Uhlen, M.1
  • 20
    • 84883670305 scopus 로고    scopus 로고
    • Recent progress in pancreatic cancer
    • Wolfgang, C.L. et al. Recent progress in pancreatic cancer. CA Cancer J. Clin. 63, 318-348 (2013
    • (2013) CA Cancer J. Clin , vol.63 , pp. 318-348
    • Wolfgang, C.L.1
  • 22
    • 84880921289 scopus 로고    scopus 로고
    • A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors
    • Hong, D.S. et al. A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors. Invest. New Drugs 31, 918-926 (2013
    • (2013) Invest. New Drugs , vol.31 , pp. 918-926
    • Hong, D.S.1
  • 23
    • 84894059672 scopus 로고    scopus 로고
    • Src inhibition is still a relevant target in pancreatic cancer
    • George, T.J. Jr., Trevino, J.G. & Liu, C. Src inhibition is still a relevant target in pancreatic cancer. Oncologist 19, 211 (2014
    • (2014) Oncologist , vol.19 , pp. 211
    • George, T.J.1    Trevino, J.G.2    Liu, C.3
  • 24
    • 33644647192 scopus 로고    scopus 로고
    • Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model
    • Trevino, J.G. et al. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am. J. Pathol. 168, 962-972 (2006
    • (2006) Am. J. Pathol , vol.168 , pp. 962-972
    • Trevino, J.G.1
  • 25
    • 33344461165 scopus 로고    scopus 로고
    • Metabolism and excretion of erlotinib, a small-molecule inhibitor of epidermal growth factor receptor tyrosine kinase, in healthy male volunteers
    • Ling, J. et al. Metabolism and excretion of erlotinib, a small-molecule inhibitor of epidermal growth factor receptor tyrosine kinase, in healthy male volunteers. Drug Metab. Dispos. 34, 420-426 (2006
    • (2006) Drug Metab. Dispos , vol.34 , pp. 420-426
    • Ling, J.1
  • 26
    • 46449088111 scopus 로고    scopus 로고
    • Metabolism and disposition of dasatinib after oral administration to humans
    • Christopher, L.J. et al. Metabolism and disposition of dasatinib after oral administration to humans. Drug Metab. Dispos. 36, 1357-1364 (2008
    • (2008) Drug Metab. Dispos , vol.36 , pp. 1357-1364
    • Christopher, L.J.1
  • 27
    • 34250694236 scopus 로고    scopus 로고
    • Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes
    • Li, J., Zhao, M., He, P., Hidalgo, M. & Baker, S.D. Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes. Clin. Cancer Res. 13, 3731-3737 (2007
    • (2007) Clin. Cancer Res , vol.13 , pp. 3731-3737
    • Li, J.1    Zhao, M.2    He, P.3    Hidalgo, M.4    Baker, S.D.5
  • 28
    • 50049093958 scopus 로고    scopus 로고
    • Identification of the human enzymes involved in the oxidative metabolism of dasatinib: An effective approach for determining metabolite formation kinetics
    • Wang, L. et al. Identification of the human enzymes involved in the oxidative metabolism of dasatinib: an effective approach for determining metabolite formation kinetics. Drug Metab. Dispos. 36, 1828-1839 (2008
    • (2008) Drug Metab. Dispos , vol.36 , pp. 1828-1839
    • Wang, L.1
  • 29
    • 84859169877 scopus 로고    scopus 로고
    • The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity
    • Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity. Nature 483, 603-607 (2012
    • (2012) Nature , vol.483 , pp. 603-607
    • Barretina, J.1
  • 30
    • 84855945142 scopus 로고    scopus 로고
    • 2nd edn. (ed. McQueen C.A.) 4.9-4.29 Elsevier, Oxford
    • Ding, X. & Zhang, Q.Y. in Comprehensive Toxicology 2nd edn. (ed. McQueen, C.A.) 4.9-4.29 (Elsevier, Oxford, 2010
    • (2010) Comprehensive Toxicology
    • Ding, X.1    Zhang, Q.Y.2
  • 31
    • 69949151386 scopus 로고    scopus 로고
    • Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
    • Jänne, P.A., Gray, N. & Settleman, J. Factors underlying sensitivity of cancers to small-molecule kinase inhibitors. Nat. Rev. Drug Discov. 8, 709-723 (2009
    • (2009) Nat. Rev. Drug Discov , vol.8 , pp. 709-723
    • Jänne, P.A.1    Gray, N.2    Settleman, J.3
  • 32
    • 0032005259 scopus 로고    scopus 로고
    • Metabolism of irinotecan (CPT-11) by human hepatic microsomes: Participation of cytochrome P450 3A and drug interactions
    • Haaz, M.C., Rivory, L., Riché, C., Vernillet, L. & Robert, J. Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P450 3A and drug interactions. Cancer Res. 58, 468-472 (1998
    • (1998) Cancer Res , vol.58 , pp. 468-472
    • Haaz, M.C.1    Rivory, L.2    Riché, C.3    Vernillet, L.4    Robert, J.5
  • 33
  • 34
    • 4644231469 scopus 로고    scopus 로고
    • The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR
    • Burk, O. et al. The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). J. Biol. Chem. 279, 38379-38385 (2004
    • (2004) J. Biol. Chem , vol.279 , pp. 38379-38385
    • Burk, O.1
  • 36
    • 0037327003 scopus 로고    scopus 로고
    • The orphan nuclear receptor HNF-4? Determines PXR- and CAR-mediated xenobiotic induction of CYP3A4
    • Tirona, R.G. et al. The orphan nuclear receptor HNF-4? determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat. Med. 9, 220-224 (2003
    • (2003) Nat. Med , vol.9 , pp. 220-224
    • Tirona, R.G.1
  • 38
    • 66049149024 scopus 로고    scopus 로고
    • Identification of an endogenous ligand bound to a native orphan nuclear receptor
    • Yuan, X. et al. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS One 4, e5609 (2009
    • (2009) PLoS One , vol.4 , pp. e5609
    • Yuan, X.1
  • 39
    • 84877934154 scopus 로고    scopus 로고
    • Pregnane X receptor (PXR) at the crossroads of human metabolism and disease
    • Koutsounas, I., Theocharis, S., Patsouris, E. & Giaginis, C. Pregnane X receptor (PXR) at the crossroads of human metabolism and disease. Curr. Drug Metab. 14, 341-350 (2013
    • (2013) Curr. Drug Metab , vol.14 , pp. 341-350
    • Koutsounas, I.1    Theocharis, S.2    Patsouris, E.3    Giaginis, C.4
  • 40
    • 84878862550 scopus 로고    scopus 로고
    • 3D structures and ligand specificities of nuclear xenobiotic receptors CAR PXR and VDR
    • Wu, B., Li, S. & Dong, D. 3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR. Drug Discov. Today 18, 574-581 (2013
    • (2013) Drug Discov. Today , vol.18 , pp. 574-581
    • Wu, B.1    Li, S.2    Dong, D.3
  • 41
    • 16644379769 scopus 로고    scopus 로고
    • Tumoral drug metabolism: Overview and its implications for cancer therapy
    • Michael, M. & Doherty, M.M. Tumoral drug metabolism: overview and its implications for cancer therapy. J. Clin. Oncol. 23, 205-229 (2005
    • (2005) J. Clin. Oncol , vol.23 , pp. 205-229
    • Michael, M.1    Doherty, M.M.2
  • 42
    • 41549114526 scopus 로고    scopus 로고
    • Xenobiotic-induced transcriptional regulation of xenobiotic-metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues
    • Pavek, P. & Dvorak, Z. Xenobiotic-induced transcriptional regulation of xenobiotic-metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr. Drug Metab. 9, 129-143 (2008
    • (2008) Curr. Drug Metab , vol.9 , pp. 129-143
    • Pavek, P.1    Dvorak, Z.2
  • 43
    • 0037478407 scopus 로고    scopus 로고
    • Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts
    • Ding, X. & Kaminsky, L.S. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 43, 149-173 (2003
    • (2003) Annu. Rev. Pharmacol. Toxicol , vol.43 , pp. 149-173
    • Ding, X.1    Kaminsky, L.S.2
  • 44
    • 27144434397 scopus 로고    scopus 로고
    • Profiling cytochrome P450 expression in ovarian cancer: Identification of prognostic markers
    • Downie, D. et al. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin. Cancer Res. 11, 7369-7375 (2005
    • (2005) Clin. Cancer Res , vol.11 , pp. 7369-7375
    • Downie, D.1
  • 45
    • 0034046572 scopus 로고    scopus 로고
    • Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line
    • Hukkanen, J. et al. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. Am. J. Respir. Cell Mol. Biol. 22, 360-366 (2000
    • (2000) Am. J. Respir. Cell Mol. Biol , vol.22 , pp. 360-366
    • Hukkanen, J.1
  • 47
    • 34047176473 scopus 로고    scopus 로고
    • Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma
    • Bergheim, I. et al. Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma. World J. Gastroenterol. 13, 997-1002 (2007
    • (2007) World J. Gastroenterol , vol.13 , pp. 997-1002
    • Bergheim, I.1
  • 48
    • 0038352146 scopus 로고    scopus 로고
    • Cytochrome P450 CYP3A4/5 expression as a biomarker of outcome in osteosarcoma
    • Dhaini, H.R. et al. Cytochrome P450 CYP3A4/5 expression as a biomarker of outcome in osteosarcoma. J. Clin. Oncol. 21, 2481-2485 (2003
    • (2003) J. Clin. Oncol , vol.21 , pp. 2481-2485
    • Dhaini, H.R.1
  • 49
    • 1942452881 scopus 로고    scopus 로고
    • Expression of cytochrome P450 in lung tumor
    • Gharavi, N. & El-Kadi, A.O.S. Expression of cytochrome P450 in lung tumor. Curr. Drug Metab. 5, 203-210 (2004
    • (2004) Curr. Drug Metab , vol.5 , pp. 203-210
    • Gharavi, N.1    El-Kadi, A.O.S.2
  • 50
    • 4644346406 scopus 로고    scopus 로고
    • Cytochrome P450 CYP1B1 activity in renal cell carcinoma
    • McFadyen, M.C., Melvin, W.T. & Murray, G.I. Cytochrome P450 CYP1B1 activity in renal cell carcinoma. Br. J. Cancer 91, 966-971 (2004
    • (2004) Br. J. Cancer , vol.91 , pp. 966-971
    • McFadyen, M.C.1    Melvin, W.T.2    Murray, G.I.3
  • 51
    • 2442679411 scopus 로고    scopus 로고
    • Expression of cytochrome P450 in tumor tissues and its association with cancer development
    • Oyama, T. et al. Expression of cytochrome P450 in tumor tissues and its association with cancer development. Front. Biosci. 9, 1967-1976 (2004
    • (2004) Front. Biosci , vol.9 , pp. 1967-1976
    • Oyama, T.1
  • 52
    • 84869426063 scopus 로고    scopus 로고
    • Cytochrome P450 in non-small-cell lung cancer related to exogenous chemical metabolism
    • Oyama, T. et al. Cytochrome P450 in non-small-cell lung cancer related to exogenous chemical metabolism. Front. Biosci. (Schol. Ed.) 4, 1539-1546 (2012
    • (2012) Front. Biosci. (Schol. Ed.) , vol.4 , pp. 1539-1546
    • Oyama, T.1
  • 53
    • 1642353685 scopus 로고    scopus 로고
    • CYP3A4 CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes
    • Schmidt, R. et al. CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes. Br. J. Cancer 90, 911-916 (2004
    • (2004) Br. J. Cancer , vol.90 , pp. 911-916
    • Schmidt, R.1
  • 54
    • 76749157232 scopus 로고    scopus 로고
    • Expressions of cytochrome P450 UDP-glucuronosyltranferase and transporter genes in monolayer carcinoma cells change in subcutaneous tumors grown as xenografts in immunodeficient nude mice
    • Sugawara, M. et al. Expressions of cytochrome P450, UDP-glucuronosyltranferase and transporter genes in monolayer carcinoma cells change in subcutaneous tumors grown as xenografts in immunodeficient nude mice. Drug Metab. Dispos. 38, 526-533 (2010
    • (2010) Drug Metab. Dispos , vol.38 , pp. 526-533
    • Sugawara, M.1
  • 55
    • 79959868909 scopus 로고    scopus 로고
    • Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells
    • Basseville, A. et al. Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells. Mol. Cancer 10, 80 (2011
    • (2011) Mol. Cancer , vol.10 , pp. 80
    • Basseville, A.1
  • 56
    • 0035071598 scopus 로고    scopus 로고
    • Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
    • Kuehl, P. et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 27, 383-391 (2001
    • (2001) Nat. Genet , vol.27 , pp. 383-391
    • Kuehl, P.1
  • 57
    • 0037518214 scopus 로고    scopus 로고
    • Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism
    • Westlind-Johnsson, A. et al. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. Drug Metab. Dispos. 31, 755-761 (2003
    • (2003) Drug Metab. Dispos , vol.31 , pp. 755-761
    • Westlind-Johnsson, A.1
  • 58
    • 84865161972 scopus 로고    scopus 로고
    • Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs
    • Walsky, R.L. et al. Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs. Drug Metab. Dispos. 40, 1686-1697 (2012
    • (2012) Drug Metab. Dispos , vol.40 , pp. 1686-1697
    • Walsky, R.L.1
  • 59
    • 51649111430 scopus 로고    scopus 로고
    • Single-cell cloning of colon cancer stem cells reveals a multilineage differentiation capacity
    • Vermeulen, L. et al. Single-cell cloning of colon cancer stem cells reveals a multilineage differentiation capacity. Proc. Natl. Acad. Sci. USA 105, 13427-13432 (2008
    • (2008) Proc. Natl. Acad. Sci. USA , vol.105 , pp. 13427-13432
    • Vermeulen, L.1
  • 60
    • 27344435774 scopus 로고    scopus 로고
    • Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
    • Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005
    • (2005) Proc. Natl. Acad. Sci. USA , vol.102 , pp. 15545-15550
    • Subramanian, A.1
  • 61
    • 79961123152 scopus 로고    scopus 로고
    • RSEM accurate transcript quantification from RNA-seq data with or without a reference genome
    • Li, B. & Dewey, C.N. RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011
    • (2011) BMC Bioinformatics , vol.12 , pp. 323
    • Li, B.1    Dewey, C.N.2
  • 62
    • 84859098571 scopus 로고    scopus 로고
    • The sva package for removing batch effects and other unwanted variation in high-throughput experiments
    • Leek, J.T., Johnson, W.E., Parker, H.S., Jaffe, A.E. & Storey, J.D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882-883 (2012
    • (2012) Bioinformatics , vol.28 , pp. 882-883
    • Leek, J.T.1    Johnson, W.E.2    Parker, H.S.3    Jaffe, A.E.4    Storey, J.D.5
  • 63
    • 84907704976 scopus 로고    scopus 로고
    • Removing batch effects for prediction problems with frozen surrogate variable analysis
    • Parker, H.S., Corrada Bravo, H. & Leek, J.T. Removing batch effects for prediction problems with frozen surrogate variable analysis. PeerJ 2, e561 (2014
    • (2014) PeerJ , vol.2 , pp. e561
    • Parker, H.S.1    Corrada Bravo, H.2    Leek, J.T.3
  • 64
    • 11244346557 scopus 로고    scopus 로고
    • Variance stabilization applied to microarray data calibration and to the quantification of differential expression
    • Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A. & Vingron, M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (suppl. 1), S96-S104 (2002
    • (2002) Bioinformatics , vol.18 , pp. S96-S104
    • Huber, W.1    Von Heydebreck, A.2    Sültmann, H.3    Poustka, A.4    Vingron, M.5
  • 65
    • 0035942271 scopus 로고    scopus 로고
    • Significance analysis of microarrays applied to the ionizing radiation response
    • Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001
    • (2001) Proc. Natl. Acad. Sci. USA , vol.98 , pp. 5116-5121
    • Tusher, V.G.1    Tibshirani, R.2    Chu, G.3
  • 66
    • 84884764745 scopus 로고    scopus 로고
    • High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
    • Stenzinger, A. et al. High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma. BMC Cancer 13, 450 (2013
    • (2013) BMC Cancer , vol.13 , pp. 450
    • Stenzinger, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.